Table 1.
Characteristic | No screening (N = 94) |
No follow-up (N = 22) |
Test/screening failure (N = 35) |
Total (N = 151) |
p valueǂ |
---|---|---|---|---|---|
Median age at diagnosis [IQR] | 53 [44–62] | 46 [36–55] | 44 [34–58] | 51 [40–59] | 0.007** |
Median year of diagnosis | 2013 | 2014 | 2013 | 2013 | 0.898 ± |
[IQR] | [2011–2016] | [2011–2016] | [2010–2016] | [2011–2016] | |
Race/Ethnicity | |||||
White, non-Hispanic | 53 (56) | 14 (64) | 27 (77) | 94 (62) | 0.527 |
Black, non-Hispanic | 26 (28) | 6 (27) | 6 (17) | 38 (25) | |
Hispanic | 11 (12) | 2 (9) | 2 (6) | 15 (10) | |
Other | 4 (4) | 0 (0) | 0 (0) | 4 (3) | |
Symptoms at diagnosis | |||||
Yes | 81 (86) | 15 (69) | 21 (60) | 117 (78) | 0.004** |
No/unknown | 13 (14) | 7 (32) | 14 (40) | 34 (22) | |
Immunocompromised | |||||
Yes | 5 (5) | 1 (5) | 1 (3) | 7 (5) | 1.000 |
No/unknown | 89 (95) | 21 (95) | 29 (97) | 144 (95) | |
Current/Past smoker | |||||
Yes | 45 (48) | 16 (73) | 10 (29) | 71 (47) | 0.005** |
No/unknown | 49 (52) | 6 (27) | 25 (71) | 80 (53) | |
Histology type | |||||
Squamous | 61 (65) | 18 (82) | 15 (43) | 94 (62) | 0.019* |
Non-squamous | 31 (33) | 4 (18) | 20 (57) | 55 (36) | |
Unknown | 2 (2) | 0 (0) | 0 (0) | 2 (1) | |
Stage (FIGO) | |||||
Stage I-IIA (local) | 45 (48) | 16 (73) | 25 (71) | 86 (57) | 0.011* |
Stage IIB-IV (advanced) | 47 (50) | 5 (23) | 8 (23) | 60 (40) | |
Unknown/missing | 2 (2) | 1 (4) | 2 (6) | 5 (3) | |
History of underinsurancea | |||||
Yes | 36 (38) | 7 (32) | 4 (11) | 47 (31) | 0.014* |
No/unknown | 58 (62) | 15 (68) | 31 (89) | 104 (69) | |
Other barriersb | |||||
None | 60 (64) | 12 (55) | 26 (74) | 98 (65) | 0.296 |
1 or more barriers | 34 (36) | 10 (45) | 9 (26) | 53 (35) |
ǂPearson’s chi-square/Fisher’s exact tests as applicable
±Wilcoxon rank-sum test
() Column percentages
IQR interquartile range
Boldface p value indicates statistical significance (*p < 0.05, **p < 0.01, ***p < 0.001)
aUnderinsurance defined as any history of no insurance or insufficient coverage, including lapses in coverage or concerns about poor insurance coverage resulting in lack or delayed receipt of healthcare services
bOther barriers includes documentation of any of the following in the five years prior to cancer diagnosis: poor English proficiency, substance use disorder, morbid obesity (body mass index ≥ 40 kg/m2), history of incarceration, history of homelessness, or serious mental illness